BillionToOne is trading 4.62% down at $95.45 on August 26, 2026; no clear company-specific announcement, filing, analyst action, or other catalyst explains the decline during the open session.
- Its latest major disclosure was the August 5 second-quarter report, which reiterated 2026 revenue guidance and is not a new August 26 catalyst.
- Biotech-sector strength does not explain today’s decline, so the cause remains unclear.